Intensjonskunngjøring · 05.03.2026

Medical equipments – 9318 Analysis platform pharmacogenic testing

SYKEHUSBYGG HF i TRONDHEIM publiserte denne kunngjøringen i TED 05.03.2026.

Type

Intensjonskunngjøring

Publisert

05.03.2026

Oppdragsgiver

SYKEHUSBYGG HF

Sted

TRONDHEIM

Art

Varer

CPV-koder

33000000, 33100000, 33120000, 38000000

TED-nummer

153649-2026

Beskrivelse

A MALDI-TOF system shall be procured for multiplex pharmacogenic genotyping for the Department of Pharmacology at Oslo University Hospital. The analysis instrument shall be able to carry out genotyping of a clinically relevant selection of pharmacogenetic variants, state special CYP2D6 gene lesions and duplications/multiplications, as well as some CYP2D6 genhybrides (compound genes). The analysis system must be able to use the manufacturer ́s ready designed panels, at the same time that self-designed analysis panels must be established for clinical use and/or research. The system must have a uniform protocol and workflow and have capacity that provides an expected laboratory engineering turnaround of 2 work days for analysing the specified pharmacogenic variation for up to 90 patient samples. The analysis system must have integrated user-friendly data acquisition software, interpretation, appraisal and reporting of analytical results. As far as the procurement project group is aware, there is only one supplier in the market who can offer the requested analyses, Agena Bioscience GmbH.

Les hele kunngjøringen og konkurransegrunnlaget hos TED · Om oppdragsgiveren (org.nr. 814630722)

Andre kunngjøringer fra SYKEHUSBYGG HF

Kilde: TED – Tenders Electronic Daily, Den europeiske unions publikasjonskontor (© EU, gjenbruk tillatt med kildehenvisning). Viser kunngjøringer som er sendt til TED (over EØS-terskelverdiene); mindre anskaffelser finnes på doffin.no. Vi er ikke oppdragsgiver og tar ikke imot tilbud.